
Opinion|Videos|June 4, 2024
Defining the Standard of Care for Early Breast Cancer Treatment
Heather Moore, BCOP, CPP, PharmD, discusses the importance of treatment for early breast cancer, highlighting the use of chemotherapy followed by endocrine therapy. She notes that CDK4/6 inhibitors are being added for higher-risk patients, and oral selective estrogen receptor degraders may also be used in advanced cases.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Unproven Hantavirus Treatments Flood Social Media
2
Ketamine’s Expanding Role in Chronic Pain and Opioid-Sparing Therapy
3
FDA Expands Respiratory Options With First Single-Inhaler Triple Therapy for Asthma Maintenance
4
Navigating GLP-1 Access: A Pharmacy Technician’s Role
5





































































































































